To find out if subclinical atherosclerosis is more common in patients of psoriasis without metabolic syndrome compared to those patients of psoriasis not having metabolic syndrome
Not Applicable
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2021/07/035003
- Lead Sponsor
- DR D Y Patil Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients with active psoriasis more than 18 years of age
2)Patients willing to undergo investigations
3)Patients willing to give consent
Exclusion Criteria
1)Patient not consenting to participate
2)Patient who are known case of cardiovascular disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of subclinical atherosclerosis in patients of psoriasis with and without metabolic syndrome.Timepoint: Baseline
- Secondary Outcome Measures
Name Time Method 1. To assess prevalence of cardiovascular risk factor and metabolic syndrome using clinical and laboratory investigations <br/ ><br>2. To assess subclinical atherosclerosis by Carotid Intima-Media thickness (CIMT) and Epicardial Fat Thickness (EFF) using B-mode ultrasound and 2D ECHO respectively. <br/ ><br>3. To correlate cardiovascular risk factors with the duration and severity of psoriasis. <br/ ><br>4. To assess prevalence of subclinical atherosclerosis in the patients with no known risk factors.Timepoint: Baseline